houttuynia
cordata
saururacea
inject
hci
tradit
chines
medicin
use
china
chosen
one
eight
type
tradit
chines
medicin
play
uniqu
role
sever
acut
respiratori
syndrom
sar
owe
effect
curb
inflamm
order
valid
plausibl
antiinflammatori
properti
chemic
composit
hci
analys
gcm
compon
identifi
inflamm
induc
carrageenan
rat
pleurisi
model
xylen
mice
ear
edema
model
adopt
studi
antiinflammatori
activ
hci
inject
carrageenan
pleural
caviti
elicit
acut
inflammatori
respons
character
protein
rich
fluid
accumul
leukocyt
infiltr
pleural
caviti
peak
inflammatori
respons
obtain
h
fluid
volum
protein
concentr
creactiv
protein
cell
infiltr
maximum
result
show
paramet
attenu
hci
dose
touch
bottom
dose
g
although
less
strong
dexamethason
drug
also
effect
inhibit
xylen
induc
ear
edema
percentag
inhibit
came
dose
g
result
clearli
indic
hci
antiinflammatori
activ
houttuynia
cordata
thunb
saururacea
tradit
medicin
plant
use
china
year
treatment
cough
leucorrhea
ureter
ji
zhao
zhou
sun
et
al
previou
studi
show
steam
distil
prepar
fresh
plant
houttuynia
cordata
thunb
possess
direct
inhibitori
activ
herp
simplex
viru
type
influenza
viru
human
immunodefici
viru
type
without
show
cytotox
hayashi
et
al
houttuynia
cordata
inject
hci
tradit
chines
medicin
use
china
dozen
year
aqueou
solut
steam
distil
plant
shown
play
uniqu
role
help
reduc
sideeffect
western
medicin
improv
immun
system
patient
infect
sever
acut
respiratori
syndrom
sar
sinc
scienc
technolog
group
nation
headquart
sar
prevent
control
set
april
eight
medicin
chosen
long
list
medicin
alreadi
use
clinic
treatment
sarshit
beij
guangdong
provinc
south
china
list
includ
hci
effect
curb
inflamm
lung
http
wwwchinanewscomcn
differ
tradit
medicin
list
lessen
fever
chill
headach
muscular
pain
malais
diarrhoea
dri
cough
lack
phlegm
antiinflammatori
effect
hci
rare
report
besid
paper
show
water
extract
dri
plant
houttuynia
cordata
kind
activ
antiedemat
action
song
order
test
whether
hci
possess
plausibl
antiinflammatori
properti
pleurisi
induc
carrageenan
ear
edema
induc
xylen
thu
use
studi
antiinflammatori
activ
hci
work
carrageenan
purchas
sigma
st
loui
mo
usa
xylen
purchas
hunan
normal
univers
changsha
hunan
provinc
china
hci
gift
hunan
zhengq
pharmaci
co
ltd
huaihua
hunan
provinc
china
dexamethason
obtain
tianjin
pharmaceut
group
corp
tianjin
china
essenti
oil
hci
prepar
accord
standard
extract
method
chines
pharmacopoeia
chines
pharmacopoeia
committe
publish
hous
peopl
health
page
appendix
essenti
oil
collect
dissolv
ml
hexan
store
refriger
c
use
gcm
analysi
perform
shimadzu
kyoto
japan
ga
chromatographi
instrument
coupl
shimadzu
mass
spectromet
compaqpro
linear
data
system
softwar
equip
capillari
column
mm
id
film
thick
column
maintain
c
min
program
c
rate
cmin
held
min
temperatur
inject
port
interfac
set
c
helium
use
carrier
ga
flow
rate
mlmin
one
microlitr
sampl
inject
split
mode
mass
spectromet
oper
electron
impact
ei
mode
ioniz
energi
ev
scan
rate
scan
mass
spectromet
oper
scan
mass
rang
amu
ioniz
sourc
temperatur
c
analyt
identifi
use
nist
mass
spectral
databas
rel
respons
individu
compon
express
percent
peak
area
rel
total
peak
area
male
wistar
rat
weigh
g
km
mice
sex
weigh
g
purchas
anim
center
central
south
univers
china
anim
kept
c
h
lightdark
cycl
free
access
water
diet
acclimat
least
week
start
experi
procedur
describ
review
approv
univers
anim
ethic
committe
ordinarili
produc
process
hci
follow
aerial
part
fresh
plant
pick
field
wash
steam
distil
obtain
essenti
oil
essenti
oil
mix
aqueou
solut
sodium
chlorid
solut
surfact
filtrat
steril
yield
hci
factori
concentr
methyl
nonyl
keton
main
compound
essenti
oil
requir
higher
gml
hci
accord
standard
specif
chines
tradit
medicin
state
standard
drug
issu
ministri
public
health
drug
treatment
induct
rat
pleurisi
mice
ear
edema
pleurisi
hci
g
g
g
bodi
weight
inject
intraven
everyday
last
day
initi
concentr
methyl
nonyl
keton
hci
gml
refer
drug
dexamethason
g
last
day
initi
concentr
dexamethason
mgml
composit
c
h
fna
pleurisi
induc
intrathorac
inject
ml
carrageenan
h
last
inject
test
drug
accord
previous
describ
method
xu
et
al
inject
carrageenan
given
seventh
eighth
rib
right
upper
limb
gaug
needl
penetr
restrict
mm
insert
care
rubber
disc
peter
et
al
shivkar
kumar
anoth
inject
treatment
drug
given
anim
h
inflammatori
stimulu
control
anim
receiv
irrit
equal
volum
steril
salin
pleural
caviti
open
rins
ml
cold
salin
contain
iuml
heparin
fluid
remov
mild
suction
volum
measur
evalu
leukocyt
count
protein
creactiv
protein
paramet
compar
rat
treat
dexamethason
control
anim
xyleneinduc
ear
edema
test
perform
previous
describ
xu
et
al
kim
et
al
mujumda
misar
hci
g
g
g
g
g
bodi
weight
inject
hypoderm
near
right
ear
twice
everyday
last
day
total
l
xylen
appli
inner
outer
surfac
right
ear
mous
min
last
inject
test
drug
left
ear
remain
untreat
control
anim
receiv
irrit
equal
volum
steril
salin
dexamethason
g
serv
refer
mice
sacrif
cervic
disloc
min
later
plug
mm
diamet
remov
stainless
steel
punch
treat
ear
untreat
ear
differ
weight
two
plug
taken
measur
oedemat
respons
thorax
rat
open
fluid
remov
mild
suction
pleural
caviti
wash
ml
cold
salin
contain
iuml
heparin
total
volum
harvest
l
pleural
fluid
dilut
ml
diluent
distil
water
contain
acet
acid
gentianviolet
total
leukocyt
count
tlc
measur
use
chamber
light
microscop
fluid
collect
pleural
caviti
centrifug
rpm
min
protein
concentr
supernat
assay
coomassi
brilliant
blue
method
high
sensit
conveni
chial
et
al
atherton
et
al
creactiv
protein
special
type
protein
produc
liver
present
episod
acut
inflamm
measur
hitachi
automat
biochem
analyz
plug
cut
mice
weigh
electron
balanc
extent
edema
express
differ
weight
plug
inflam
untreat
ear
kaur
et
al
koo
et
al
percentag
inhibit
calcul
follow
percentag
inhibit
edema
extent
control
edema
extent
treat
edema
extent
control
valu
express
mean
sem
analys
use
oneway
analysi
varianc
anova
test
calcul
signific
result
essenti
oil
hci
analys
compon
identifi
result
analys
show
main
compound
hci
methyl
nonyl
keton
bornyl
acet
ndecano
acid
caryophyllen
docosano
acid
ethyl
ester
tabl
peak
area
compon
compar
total
peak
area
methyl
nonyl
keton
main
activ
compon
hayashi
et
al
intrapleur
administr
carrageenan
produc
acut
inflammatori
respons
mark
exud
respons
obtain
peak
h
follow
declin
exampl
volum
pleural
fluid
increas
ml
h
ml
h
decreas
ml
h
protein
concentr
exud
measur
differ
timeinterv
show
increas
h
mgml
h
declin
mgml
h
similar
trend
cell
count
creactiv
protein
observ
antiinflammatori
effect
hci
studi
carrageenan
induc
pleurisi
compar
dexamethason
use
standard
drug
antiinflammatori
effect
drug
studi
h
dose
antiinflammatori
drug
produc
signific
decreas
exud
volum
compar
control
ml
although
antiinflamm
hci
dose
less
strong
dexamethason
tabl
hci
three
dose
show
signific
differ
respect
control
protein
concentr
exud
administr
three
dose
decreas
mgml
administr
steril
salin
mgml
respect
effect
dose
g
compar
dexamethason
tabl
result
hci
decreas
capillari
permeabl
suppress
inflammatori
cell
influx
reduc
creactiv
protein
concentr
hci
dose
g
effect
compar
dose
g
g
dexamethason
tabl
data
tabl
antiinflammatori
effect
hci
carrageenan
induc
pleurisi
g
prefer
differ
weight
two
plug
taken
measur
oedemat
respons
reach
maximum
min
follow
declin
embroc
xylen
topic
antiinflammatori
activ
hci
evalu
inhibit
xyleneinduc
ear
edema
mice
xyleneinduc
mous
ear
edema
method
certain
advantag
natur
product
test
good
predict
valu
screen
antiinflammatori
agent
jacob
et
al
effect
hci
xyleneinduc
ear
edema
mice
shown
tabl
topic
applic
xylen
induc
cutan
inflamm
ear
mice
caus
signific
increas
ear
plug
weight
right
ear
compar
left
ear
hci
hypoderm
appli
dose
l
per
g
bodi
weight
provid
inhibitori
effect
xyleneinduc
ear
edema
format
dosedepend
manner
tabl
treatment
hci
g
gave
inhibit
ear
plug
weight
tabl
indic
hci
contain
antiinflammatori
activ
posit
control
dexamethason
g
gave
rise
signific
inhibit
ear
plug
weight
tabl
note
effect
treatment
hci
dose
g
signific
may
attribut
extra
dose
bring
hypoderm
damag
inflamm
result
antiinflammatori
effect
dose
decreas
although
antiinflammatori
effect
hci
less
strong
dexamethason
tabl
consider
hci
tabl
antiinflammatori
effect
hci
xylen
induc
ear
edema
extent
edema
mg
percentag
inhibit
control
dexamethason
hci
g
g
g
g
g
data
repres
mean
differ
ear
weight
mg
sem
n
p
signific
compar
control
complic
mixtur
suggest
activ
principl
would
strong
antiinflammatori
effect
result
agre
result
obtain
carrageenan
induc
pleurisi
test
tabl
result
obtain
two
model
hci
effect
curb
inflamm
consist
clinic
result
song
accord
observ
song
hci
brought
fever
cough
asthma
elimin
rale
capillari
bronchiti
symptom
also
appear
sar
could
suppos
effect
curb
sar
involv
antiinflammatori
effect
cours
need
valid
abound
research
result
present
studi
reveal
antiinflammatori
activ
hci
mice
ear
edema
induc
xylen
rat
pleurisi
induc
carrageenan
model
